1. Home
  2. RGEN vs MOS Comparison

RGEN vs MOS Comparison

Compare RGEN & MOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • MOS
  • Stock Information
  • Founded
  • RGEN 1981
  • MOS 1987
  • Country
  • RGEN United States
  • MOS United States
  • Employees
  • RGEN N/A
  • MOS N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • MOS Agricultural Chemicals
  • Sector
  • RGEN Health Care
  • MOS Industrials
  • Exchange
  • RGEN Nasdaq
  • MOS Nasdaq
  • Market Cap
  • RGEN 6.5B
  • MOS 10.4B
  • IPO Year
  • RGEN N/A
  • MOS 2004
  • Fundamental
  • Price
  • RGEN $113.54
  • MOS $33.65
  • Analyst Decision
  • RGEN Buy
  • MOS Buy
  • Analyst Count
  • RGEN 10
  • MOS 12
  • Target Price
  • RGEN $163.78
  • MOS $36.67
  • AVG Volume (30 Days)
  • RGEN 700.4K
  • MOS 4.2M
  • Earning Date
  • RGEN 11-11-2025
  • MOS 11-11-2025
  • Dividend Yield
  • RGEN N/A
  • MOS 2.62%
  • EPS Growth
  • RGEN N/A
  • MOS 292.19
  • EPS
  • RGEN N/A
  • MOS 2.95
  • Revenue
  • RGEN $673,956,000.00
  • MOS $11,253,400,000.00
  • Revenue This Year
  • RGEN $16.74
  • MOS $19.19
  • Revenue Next Year
  • RGEN $13.86
  • MOS N/A
  • P/E Ratio
  • RGEN N/A
  • MOS $11.40
  • Revenue Growth
  • RGEN 8.73
  • MOS N/A
  • 52 Week Low
  • RGEN $102.97
  • MOS $22.36
  • 52 Week High
  • RGEN $182.52
  • MOS $38.23
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 40.89
  • MOS 53.06
  • Support Level
  • RGEN $117.18
  • MOS $32.09
  • Resistance Level
  • RGEN $122.71
  • MOS $33.81
  • Average True Range (ATR)
  • RGEN 4.36
  • MOS 0.75
  • MACD
  • RGEN -0.55
  • MOS 0.18
  • Stochastic Oscillator
  • RGEN 6.59
  • MOS 78.14

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About MOS Mosaic Company (The)

Mosaic is one of the largest phosphate and potash producers in the world. The company's assets include phosphate rock mines in Florida, Brazil, and Peru and potash mines in Saskatchewan, New Mexico, and Brazil. Mosaic also runs a large fertilizer distribution operation in Brazil through its Mosaic Fertilizantes business.

Share on Social Networks: